Evidence map›Paper›PMID 39107569›Full record

ArticleInflammation2025

ZC3H13-Mediated m6A Modification Ameliorates Acute Myocardial Infarction through Preventing Inflammation, Oxidative Stress and Ferroptosis by Targeting lncRNA93358.

Jiumei Cai, Xiaoping Wang, Ziliang Wang, Shanhui Sheng, Fosheng Tang, Zhiwei Zhang

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jiumei CaiDepartment of Cardiology, First Affiliated Hospital of Gannan Medical University, No.128 Jinling West Road, Ganzhou City, 341000, Jiangxi Province, China.
Xiaoping WangDepartment of Cardiology, First Affiliated Hospital of Gannan Medical University, No.128 Jinling West Road, Ganzhou City, 341000, Jiangxi Province, China.
Ziliang WangDepartment of Cardiology, First Affiliated Hospital of Gannan Medical University, No.128 Jinling West Road, Ganzhou City, 341000, Jiangxi Province, China.
Shanhui ShengDepartment of Cardiology, First Affiliated Hospital of Gannan Medical University, No.128 Jinling West Road, Ganzhou City, 341000, Jiangxi Province, China.
Fosheng TangGannan Medical University, No.1 Hexie Avenue, Ganzhou City, 341000, Jiangxi Province, China.
Zhiwei ZhangDepartment of Pediatric Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, No. 106 Zhongshan Er Road, Guangzhou City, 510080, Guangdong Province, China. drzhangzw@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAcute myocardial infarction (AMI) is a life-threatening event that is associated with RNA modification and programmed cell death (PCD). This study attempted to investigate the impacts of zinc finger CCCH domain-containing protein 13 (ZC3H13)-mediated N6-methyladenosine (m6A) on ferroptosis in AMI.

methodsThe infarcted areas and cardiac function were evaluated, and the expression level of ZC3H13 was measured in AMI rats that were induced by isoproterenol. Meanwhile, oxygen glucose deprivation (OGD) in vitro model was induced to investigate the alterations on inflammation, oxidative stress and ferroptosis. The m6A modification site of lncRNA93358 modified by ZC3H13 was predicted using bioinformatics, and the interaction between ZC3H13 and lncRNA93358 was verified using the dual-luciferase reporter assays. ZC3H13 was overexpressed and lncRNA93358 was silenced to study their regulatory role in cell death, inflammation, oxidative stress and ferroptosis in AMI.

resultsSignificant decreased expression of ZC3H13 was observed in AMI rats, with impaired cardiac function, enhanced inflammation and oxidative stress. ZC3H13 targeted the modification site GGACC of lncRNA93358 and downregulated lncRNA93358. Silencing lncRNA93358 inhibited cell death, reduced the levels of inflammatory cytokines tumor necrosis factor (TNF)-α, interleukin (IL)-6 and IL-1β, suppressed oxidative stress-related indicators (lactate dehydrogenase (LDH), reactive oxygen species (ROS), glutathione (GSH) and malondialdehyde (MDA), as well as downregulated ferroptosis-related acyl-CoA synthetase long chain family member 4 (ACSL4), prostaglandin-endoperoxide synthase 2 (PTGS2) and glutathione peroxidase 4 (GPX4). The effect of silencing lncRNA93358 was further enhanced by overexpression of ZC3H13.

conclusionThis study reveals the ZC3H13-mediated epigenetic RNA modification targeting lncRNA93358 and suggests that ZC3H13 overexpression may be a promising approach for AMI treatment.

Indexed as

AdenosineFerroptosisInflammationMyocardial InfarctionOxidative StressRNA, Long NoncodingAnimalsMaleMyocytes, CardiacRatsRats, Sprague-DawleyAdenosineN-methyladenosineRNA, Long NoncodingAcute myocardial infarctionFerroptosisLncRNA93358RNA modificationZC3H13

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.